«12345›»Seite
5 Artikel mit Literatur, Seite 5 von 5

MEDIZIN

Zervixkarzinom, HPV-Infektion und Screening: Stand der Dinge und Zukunftsperspektiven

Dtsch Arztebl 2003; 100(3): A-132 / B-120 / C-116

Klug, Stefanie; Blettner, Maria

1. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland: Krebs in Deutschland, Häufigkeiten und Trends. 3. erweiterte, aktualisierte Ausgabe. Saarbrücken, 2002.
2. Bastian L, Datta S, Hasselblad V et al.: Evaluation of cervical cytology. AHCPR Publication No 99-E010, 1999.
3. Bauer HM, Hildesheim A, Schiffman MH et al.: Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993; 20: 274–278. MEDLINE
4. Bauer HM, Ting Y, Greer CE et al.: Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265: 472–477. MEDLINE
5. Bosch FX, Lorincz A, Munoz N et al.: The casual relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244–265. MEDLINE
6. Braly P: Preventing cervical cancer. Nat Med 1996; 2: 749–751. MEDLINE
7. Burk RD, Kelly P, Feldman J et al.: Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996; 23: 333–341. MEDLINE
8. Chaouki N, Bosch FX, Munoz N et al.: The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998; 75: 546–554. MEDLINE
9. Chichareon S, Herrero R, Munoz N et al.: Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998; 90: 50–57. MEDLINE
10. Coleman D, Day N, Douglas G et al.: European guidelines for quality assurance in cervical cancer screening. Europe against cancer programme. Eur J Cancer 1993; 29A Suppl 4: S1–38. MEDLINE
11. Cuzick J, Sasieni P, Davies P et al.: A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999; 3: 1–204. MEDLINE
12. de Roda H, Walboomers JM, van den Brule AJ et al.: The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057–1062. MEDLINE
13. de Sanjose S, Bosch FX, Munoz N et al.: Social differences in sexual behaviour and cervical cancer. IARC Sci Publ 1997; 138: 309–317. MEDLINE
14. Eluf-Neto J, Booth M, Munoz N et al.: Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69: 114–119. MEDLINE
15. Epidemiologisches Krebsregister Saarland. Jahresbericht Krebsregister Saarland 1996/97. Ministerium für Frauen, Arbeit und Soziales, Saarland Dezember 2000. Daten aktualisiert 2001 (Krebsregister@stala.saarland.de)
16. Ferlay J, Pisani P, Parkin DM: GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. 2001. Lyon, IARCpress.
17. Gemeinsames Krebsregister der Länder Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen-Anhalt und der Freistaaten Sachsen und Thüringen. Sonderbericht: Das Gemeinsame Krebsregister 1995– 1999. Schriftenreihe des GKR 4/2001. Medialis Druck, Berlin. Daten aktualisiert 2001 (registerstelle@gkr.verwalt-berlin.de)
18. Government Statistical Service Bulletin, England 1998–99. England, Department of Health Statistical Bulletin: Cervical screening programme. www.doh. gov.uk/public/sb9932.htm
19. Gravitt PE, Peyton CL, Alessi TQ et al.: Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357–361. MEDLINE
20. Herrero R, Munoz N: Human papillomavirus and cancer. Cancer Surv 1999; 33: 75–97.
21. Hildesheim A, Gravitt P, Schiffman MH et al.: Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis 1993; 20: 279–285. MEDLINE
22. Hilgarth M: Gedanken zur Qualitätssicherung der gynäkologischen Krebsvorsorge des Zervixkarzinoms und seiner Vorstufen. Geburtshilfe Frauenheilkd 1998; 58: M157–M158.
23. Hilgarth M: Münchner Nomenklatur II für die gynäkologische Zytodiagnostik. Frauenarzt 2001; 39: 392–393.
24. Hill AB: The environment and disease: association or causation? Proc Roy Soc Med 1965; 58: 295–300.
25. Ho GY, Bierman R, Beardsley L et al.: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423–428. MEDLINE
26. Ho GY, Burk RD, Klein S et al.: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365–1371. MEDLINE
27. IARC: Human Papillomaviruses. Lyon, France: Monographs on the evaluation of carcinogenic risk to humans, Vol. 64, 1995.
28. Josefsson AM, Magnusson PK, Ylitalo N et al.: Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355: 2189–2193. MEDLINE
29. Kahl H, Hölling H, Kamtsiuris P: Inanspruchnahme von Früherkennungsuntersuchungen und Maßnahmen zur Gesundheitsförderung. Gesundheitswesen 1999; 61: 163–168. MEDLINE
30. Kassenärztliche Bundesvereinigung. Beteiligung an den Früherkennungsuntersuchungen in der GKV seit 1972. Grunddaten zur vertragsärztlichen Versorgung in der Bundesrepublik Deutschland. Fachbereich Bedarfsplanung und Bundesarztregister, 1999. (www.kbv.de, April 2001)
31. Kim J, Wright TC, Goldie SJ: Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002; 287: 2382–2390. MEDLINE
32. Kjaer SK, van den Brule AJ, Bock JE et al.: Human papillomavirus – the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996; 65: 601–606. MEDLINE
33. Koch J, Kirschner W, Schäfer A: Bestimmung der Prävalenz genitaler HPV- and Chlamydia-trachomatis-Infektionen in einem repräsentativen Querschnitt der weiblichen Normalbevölkerung in Berlin. Infektionsepidemiol Forschung 1997; 2: 1–7.
34. Koopmanschap MA, van Oortmarssen GJ, van Agt HM et al.: Cervical-cancer screening: attendance and cost-effectiveness. Int J Cancer 1990; 45: 410–415. MEDLINE
35. Koutsky LA, Holmes KK, Critchlow CW et al.: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327: 1272–1278. MEDLINE
36. Mandelblatt J, Lawrence W, Womack S: Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002; 287: 2372–2381. MEDLINE
37. Meijer CJLM, Rozendaal L, van der Linden JC et al.: Human papillomavirus testing for primary cervical cancer screening. In: Franco E, Monsonego J, eds.: New development in Cervical Cancer Screening and Prevention. Oxford: Blackwell Science, 1997: 338–347.
38. Meijer CJLM, Snijders P, van den Brule AJC: Screening for cervical cancer: Should we test for infection with high-risk HPV? CMAJ 2000; 163: 535–538. MEDLINE
39. Miller AB: Cervical cancer screening programmes: managerial guidelines. Geneva: World Health Organization, 1992.
40. Munoz N, Bosch FX, de Sanjose S et al.: The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52: 743–749. MEDLINE
41. Munoz N, Kato I, Bosch FX et al.: Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis 1996; 23: 504–510. MEDLINE
42. Ngelangel C, Munoz N, Bosch FX et al.: Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998; 90: 43–49. MEDLINE
43. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ et al.: Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999; 354: 20–25. MEDLINE
44. Papanicolaou GN: Survey of the actualities and potentialities of exfoliative cytology in cancer diagnosis. Ann Int Med 1949; 31: 661–674.
45. Payne N, Chilcott J, McGoogan E: Liquid-based cytology in cervical screening: a rapid and systematic review. Health Technol Assess 2000; 4: 1–73. MEDLINE
46. Rolon PA, Smith JS, Munoz N et al.: Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000; 85: 486–491. MEDLINE
47. Rothman KJ: Causes. Am J Epidemiol 1976; 141: 90–95. MEDLINE
48. Santos C, Munoz N, Klug SJ et al.: HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001; 85: 966–971. MEDLINE
49. Schiffman MH, Bauer HM, Hoover RN et al.: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958–964. MEDLINE
50. Schlecht NF, Kulaga S, Robitaille J et al: Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286: 3106–3114. MEDLINE
51. Schneider A, Dürst M, Klug SJ et al.: Epidemiologie, Ätiologie und Prävention des Zervixkarzinoms. Onkologe 2001; 7: 814–826.
52. Schneider A, Gissmann L: Prävention des Zervixkarzinoms: Screening und Impfen. Onkologe 2002; 8: 1053–1063.
53. Schneider A, Hoyer H, Dürst M: Bedeutung des Nachweises von humanen Papillomviren für die Vorsorge. Dtsch Arztebl 2001; 98: A2517–A2521 [Heft 39]. VOLLTEXT
54. Schneider A, Hoyer H, Lotz B et al.: Screening for high grade cervical intraepithelial neoplasia and cancer by testing for high risk HPV, routine cytology or colposcopy. Int J Cancer 2000; 89: 529–534. MEDLINE
55. Sellors JW, Mahony JB, Kaczorowski J et al.: Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000; 163: 503–508. MEDLINE
56. Soost HJ: Ergebnisse zytologischer Krebsfrüherkennungs- und Vorsorgeuntersuchungen bei der Frau. Köln: Deutscher Ärzte-Verlag 1987.
57. Statistisches Bundesamt. Gesundheitsbericht für Deutschland/Gesundheitsberichterstattung des Bundes. Stuttgart: Metzler Poeschel 1998.
58. van Ballegooijen M, van den Akker-van Marle ME, Warmerdam PG et al.: Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness. Br J Cancer 1997; 76: 651–657. MEDLINE
59. van den Brule AJ, Walboomers JM, Du MM et al.: Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991; 48: 404–408. MEDLINE
60. van der Graaf Y, Molijn A, Doornewaard H et al.: Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 2002; 156: 158–164. MEDLINE
61. van Duin M, Snijders PJ, Schrijnemakers HF et al.: Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002; 98: 590–595. MEDLINE
62. Walboomers JM, Jacobs MV, Manos MM et al.: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12–19. MEDLINE
63. Wallin KL, Wiklund F, Angstrom T et al.: Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999; 341: 1633–1638. MEDLINE
64. Wheeler CM, Parmenter CA, Hunt WC et al.: Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 1993; 20: 286–289. MEDLINE
65. Woodman CB, Collins S, Winter H et al.: Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357: 1831–1836. MEDLINE
66. Ylitalo N, Sorensen P, Josefsson AM et al.: Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355: 2194–2198. MEDLINE
67. zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991; 184: 9–13. MEDLINE
68. zur Hausen H: Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994; 186: 131–156. MEDLINE
69. zur Hausen H: Papillomaviren als Krebserreger. Geburtshilfe Frauenheilkd 1998; 58: 291–196.
70. zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690–698. MEDLINE
«12345›»Seite
5 Artikel mit Literatur, Seite 5 von 5

Login

E-Mail

Passwort


Passwort vergessen?

Registrieren

Eingeloggt als

Suchen in